Economic impact of angioplasty salvage techniques, with an emphasis on coronary stents: A method incorporating costs, revenues, clinical effectiveness and payer mix

Journal of the American College of Cardiology

Volumn 30, Issue 4, 1997, Pages 894-900

  Vaitkus, Paul T ^a,b,c,d   Witmer, William T ^a,c   Brandenburg, Richard G ^b   Wells, Susannah K ^c   Zehnacker, Jonathan B ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c FLETCHER ALLEN HEALTH CARE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; ECONOMIC ASPECT; HEALTH CARE COST; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERVENTIONAL RADIOLOGY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SALVAGE THERAPY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAPITATION FEE; COST SAVINGS; DIAGNOSIS-RELATED GROUPS; FEE-FOR-SERVICE PLANS; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; INCOME; MARKETING OF HEALTH SERVICES; SALVAGE THERAPY; STENTS; TREATMENT OUTCOME; VERMONT;

EID: 0030865309     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00251-9     Document Type: Article

References (28)

1. Cohen DJ, Breall JA, Ho KKL, et al. Economies of elective coronary revascularization: comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol 1993;22:1052-9.
2. Ellis SE, Miller DP, Brown KJ, et al. In-hospital cost of percutaneous coronary revascularization: critical determinants and implications. Circulation 1995;92:741-7.
3. Wolfe MW, Roubin GS, Schweiger M, et al. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: clinical and procedural predictors. Circulation 1995;92:311-9.
4. Pilon C, Foley B, Penn IA, Brown RIG. A costing study of coronary stenting in failed angioplasty [abstract]. J Am Coll Cardiol 1994;23 Suppl A:73A.
5. Weintraub WS, Mauldin P, Gilbert S, Hicks F, Canup D. Pre and post procedure correlates of in-hospital costs of PTCA [abstract]. J Am Coll Cardiol 1994;23 Suppl A:283A.
6. Dick RJ, Popma JJ, Muller DWM, Burek KA, Topol EJ. In-hospital costs associated with new percutaneous coronary devices. Am J Cardiol 1991;68: 879-85.
7. Nino CL, Freed M, Blankenship L, Grines CL, O'Neill WW, Safian RD. Procedural costs of new interventional devices. Am J Cardiol 1994;74: 1165-6.
8. Guzman LA, Simpfendorfer C, Fix J, Franco I, Whitlow PL. Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease. Am J Cardiol 1994;74:22-5.
9. Pepine CJ, Holmes DR, Block PC, et al. Coronary artery stents. J Am Coll Cardiol 1996;28:782-94.
10. Bergelson BA, Fishman RF, Tommaso CL, et al. Acute and long-term outcome of failed percutaneous transluminal coronary angioplasty treated by directional coronary atherectomy. Am J Cardiol 1994;73:1224-6.
11. Scott NA, Weintraub WS, Carlin SF, et al. Recent changes in the manage-ment and outcome of acute closure after percutaneous transluminal coronary angioplasty. Am J Cardiol 1993;71:1159-63.
12. Lincoff AM, Popma JJ, Ellis SE, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographie and therapeutic profile. J Am Coll Cardiol 1992;19:926-35.
13. de Feyter PJ, de Jaegere PT, Serruys PW. Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J 1994;127:643-51.
14. Gablian G, Deligonul V, Kern M, Vandormael M. Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: temporal relation to discontinuation of anticoagulation. Am Heart J 1988; 116:696-700.
15. Popma JJ, Redwood SR, Chuang YC, et al. Procedure-related complications are the major contributors of incremental in-hospital costs after angioplasty [abstract]. Circulation 1995;92 Suppl 1:1-662.
16. Lindsay J, Hong MK, Pinnow EE, Pichard AD. Effects of endoluminal coronary stents on the frequency of coronary artery bypass grafting after unsuccessful percutaneous transluminal coronary revascularization. Am J Cardiol 1996;77:647-9.
17. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographie outcomes. J Am Coll Cardiol 1993;22:135-43.
18. van der Linden LP, Bakx ALM, Sedney MI, Buis B, Bruschke AVG. Prolonged dilation with an autoperfusion balloon catheter for refractory acute occlusion related to percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:1016-23.
19. Jackman JD, Zidar JP, Tcheng JE, Overman AB, Phillips HR, Stack RS. Outcome after prolonged balloon inflations of >20 minutes for initially unsuccessful percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;69:1417-21.
20. Friedman HZ, Cragg DR, Glazier SM, et al. Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty. J Am Coll Cardiol 1994;24:1214-9.
21. Vaitkus PT, Herrman HC, Laskey WK. Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J 1992;124:1-8.
22. Vaitkus PT, Laskey WK. Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1994; 24:1415-23.
23. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989;262:2879-86.
24. Microsoft Corporation. Using iteration to solve a circular reference formula. Microsoft Excel User's Guide 2, 1993:13-4.
25. Altmann DB, Racz M, Battleman DS, et al. Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J 1997;132:503-7.
26. Woolhandler S, Himmelstein DU. Extreme risk - the new corporate proposition for physicians. N Engl J Med 1995;333:1706-8.
27. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized trial. Circulation 1995;92:2480-7.
28. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.